Adalimumab-adbm

Next

Cyltezo® ,

Adalimumab-adbm

Disease
Crohn's disease , Ulcerative colitis ,
Drug Class
Biologics/Biosimilars
Delivery Method
Injection or
Brand name:
Cyltezo®

(This drug is a biosimilar to Humira®)

,
Drug name:
Adalimumab-adbm
Drug type
Anti-TNF
Recommendations for pregnancy

Effects to fetus are unknown

Recommendations for breastfeeding

Present in breast milk; talk to your doctor

Most common side effects

Common side-effects include injection site reactions such as redness, rash, swelling itching, pain or bruising; upper respiratory infections (including sinus infections); headaches, rash, and nausea.

Other

Serious infections have included tuberculosis (TB) and other infections such as viruses, fungi, or bacteria that have spread throughout the body. For children and adults, the chance of getting lymphoma and other cancers may increase. Cyltezo® is an FDA approved interchangeable biosimilar to Humira® (adalimumab). 

Learn more about Biologics/Biosimilars

Adalimumab-abdn

Video Length

Adalimumab-abdn